This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $4,647.12 firm-fixed-price contract provides for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. The contract has an ultimate completion date of September 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply a wide range of medications, medical supplies, and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $19,997.68 firm fixed-price contract is for the delivery of 4,565,860,590 units of the pharmaceutical product MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract has an ultimate completion date of September 19, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, has been awarded numerous...
This is a $4,647.12 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML pharmaceutical products. The contract has an ultimate completion date of July 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these medical supplies to support military treatment facilities and other federal healthcare providers. The award is not associated with a set-aside program....
This is a $1,936.25 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,242,943 units of the pharmaceutical product MONOVISC 88 MG/4 ML SYRINGE 4ML, with an ultimate completion date of July 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of its broader role as an Indefinite Delivery Contract (IDC) holder with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,905.57 firm fixed-price contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a period of performance through May 9, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,739.34, is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical supply. The contract is a firm fixed-price delivery order with a completion date of June 12, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $56,896.00 firm-fixed-price contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML medical products. The contract has an ultimate completion date of January 30, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $6,392.25 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major procurement arm of the U.S. Department of Defense, to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4564591038 MONOVISC 88 mg/4 ml syringes, a pharmaceutical product used in medical treatments. Amerisourcebergen is a major pharmaceutical distribution company that holds significant indefinite delivery contracts...
This is a $13,643.69 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, with a period of performance through April 16, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, primarily serving the Department of Defense (DoD) and...
This is a $4,647.12 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML medical products. The delivery period runs through September 13, 2024. This order is not associated with any set-aside program. AmerisourceBergen is a major supplier of pharmaceuticals and medical supplies to the federal government, holding several Indefinite Delivery...